These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4822470)

  • 41. Mortality among individuals exposed to atomic bomb radiation in utero: 1950-2012.
    Sugiyama H; Misumi M; Sakata R; Brenner AV; Utada M; Ozasa K
    Eur J Epidemiol; 2021 Apr; 36(4):415-428. PubMed ID: 33492551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
    Otake M; Schull WJ
    Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic effects of radiation in atomic-bomb survivors and their children: past, present and future.
    Nakamura N
    J Radiat Res; 2006; 47 Suppl B():B67-73. PubMed ID: 17019054
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigation of circular asymmetry in cancer mortality of Hiroshima and Nagasaki A-bomb survivors.
    Peterson AV; Prentice RL; Ishimaru T; Kato H; Mason M
    Radiat Res; 1983 Jan; 93(1):184-99. PubMed ID: 6823505
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.
    Thompson DE; Mabuchi K; Ron E; Soda M; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Izumi S
    Radiat Res; 1994 Feb; 137(2 Suppl):S17-67. PubMed ID: 8127952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
    Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
    Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Some further observations on the sex ratio among infants born to survivors of the atomic bombings of Hiroshima and Nagasaki.
    Schull WJ; Neel JV; Hashizume A
    Am J Hum Genet; 1966 Jul; 18(4):328-38. PubMed ID: 5945952
    [No Abstract]   [Full Text] [Related]  

  • 48. Genetic effects of the atomic bombs: a reappraisal.
    Schull WJ; Otake M; Neel JV
    Science; 1981 Sep; 213(4513):1220-7. PubMed ID: 7268429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ionizing radiation exposure and the development of soft-tissue sarcomas in atomic-bomb survivors.
    Samartzis D; Nishi N; Cologne J; Funamoto S; Hayashi M; Kodama K; Miles EF; Suyama A; Soda M; Kasagi F
    J Bone Joint Surg Am; 2013 Feb; 95(3):222-9. PubMed ID: 23389785
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Future population of atomic bomb survivors in Nagasaki.
    Yokota K; Mine M; Shibata Y
    Stud Health Technol Inform; 2013; 192():952. PubMed ID: 23920726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The children of atomic bomb survivors: a synopsis.
    Schull WJ
    J Radiol Prot; 2003 Dec; 23(4):369-84. PubMed ID: 14750686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An epidemiological study on leukemia in survivors exposed to the atomic bomb in childhood in Hiroshima. I.
    Shimizu K
    Hiroshima J Med Sci; 1968 Sep; 17(3):123-9. PubMed ID: 5717115
    [No Abstract]   [Full Text] [Related]  

  • 53. Ionizing radiation and leukemia mortality among Japanese Atomic Bomb Survivors, 1950-2000.
    Richardson D; Sugiyama H; Nishi N; Sakata R; Shimizu Y; Grant EJ; Soda M; Hsu WL; Suyama A; Kodama K; Kasagi F
    Radiat Res; 2009 Sep; 172(3):368-82. PubMed ID: 19708786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Hyperparathyroidism.
    Fujiwara S
    J Radiat Res; 1991 Mar; 32 Suppl():245-8. PubMed ID: 1762112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stable chromosome aberrations in atomic bomb survivors: results from 25 years of investigation.
    Kodama Y; Pawel D; Nakamura N; Preston D; Honda T; Itoh M; Nakano M; Ohtaki K; Funamoto S; Awa AA
    Radiat Res; 2001 Oct; 156(4):337-46. PubMed ID: 11554845
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mean bone marrow dose of atomic bomb survivors in Hiroshima and Nagasaki.
    Hashizume T; Maruyama T; Nishizawa K; Fukuhisa K
    J Radiat Res; 1977 Mar; 18(1):67-83. PubMed ID: 853474
    [No Abstract]   [Full Text] [Related]  

  • 57. Studies on the Hiroshima and Nagasaki survivors, and their use in estimating radiation risks.
    Muirhead CR
    Radiat Prot Dosimetry; 2003; 104(4):331-5. PubMed ID: 14579889
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies of cancer among the Japanese A-bomb survivors.
    Beebe GW
    Cancer Invest; 1988; 6(4):417-26. PubMed ID: 3179774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. At the 75th anniversary of the bombings of Hiroshima and Nagasaki, the Radiation Effects Research Foundation continues studies of the atomic bomb survivors and their children.
    Samet JM; Niwa O
    Carcinogenesis; 2020 Nov; 41(11):1471-1472. PubMed ID: 33017841
    [No Abstract]   [Full Text] [Related]  

  • 60. Analysis of cancer mortality among atomic bomb survivors registered at Hiroshima University.
    Matsuura M; Hoshi M; Hayakawa N; Shimokata H; Ohtaki M; Ikeuchi M; Kasagi F
    Int J Radiat Biol; 1997 May; 71(5):603-11. PubMed ID: 9191905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.